Technical Analysis for NBIX - Neurocrine Biosciences, Inc.

Grade Last Price % Change Price Change
grade D 79.79 1.62% 1.27
NBIX closed up 1.62 percent on Wednesday, May 22, 2019, on 47 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical NBIX trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Multiple of Ten Bearish Other 0.00%
Crossed Above 20 DMA Bullish 1.62%
Bollinger Band Squeeze Range Contraction 1.62%
Fell Below 20 DMA Bearish 4.06%
Bollinger Band Squeeze Range Contraction 4.06%
20 DMA Support Bullish 0.96%
Bollinger Band Squeeze Range Contraction 0.96%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.26%

Older signals for NBIX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Neurocrine Biosciences, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. It develops drugs for endometriosis, tardive dyskinesia, uterine fibroids, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. The company's products in clinical development include Elagolix, a Phase III drug for endometriosis; Vesicular Monoamine Transporter 2 Inhibitor (VMAT2), a Phase II drug for movement disorders; CRF2 Peptide Agonist, a Phase II drug for cardiovascular diseases; CRF1 Antagonist, a Phase II drug for stress-related disorders; and Elagolix, a Phase II drug for uterine fibroids. Its research programs comprise G Protein-Coupled Receptor 119 (GPR119) for type II diabetes; VMAT2 for schizophrenia; gonadotropin-releasing hormone (GnRH) Antagonists for men's and women's health, and oncology; Antiepileptic Drugs for epilepsy, essential tremor, and pain; and G Protein-Coupled Receptors for other conditions. The company has collaborations with AbbVie Inc. to develop and commercialize elagolix and GnRH antagonists for women's and men's health; Boehringer Ingelheim International GmbH to research, develop, and commercialize small molecule GPR119 agonists for the treatment of Type II diabetes and other indications; and Dainippon Sumitomo Pharma Co. Ltd. to develop and commercialize indiplon in Japan. Neurocrine Biosciences, Inc. was founded in 1992 and is headquartered in San Diego, California.
Chemistry Pain Diabetes Disorders Schizophrenia Alcohols Cardiovascular Diseases Hormones Epilepsy Ethers Movement Disorders Ii Diabetes Pyrimidines Gnrh Antagonists Endometriosis Gonadotropin Releasing Hormone Antagonist Insomnia Uterine Fibroids
Is NBIX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 126.98
52 Week Low 64.72
Average Volume 885,089
200-Day Moving Average 93.984
50-Day Moving Average 82.7064
20-Day Moving Average 77.951
10-Day Moving Average 78.56
Average True Range 3.0331
ADX 27.45
+DI 16.5311
-DI 24.6237
Chandelier Exit (Long, 3 ATRs ) 72.959
Chandelier Exit (Short, 3 ATRs ) 80.94929999999999
Upper Bollinger Band 81.7865
Lower Bollinger Band 74.1155
Percent B (%b) 0.74
BandWidth 9.840797
MACD Line -0.8818
MACD Signal Line -1.2468
MACD Histogram 0.365
Fundamentals Value
Market Cap 7.04 Billion
Num Shares 88.2 Million
EPS -2.52
Price-to-Earnings (P/E) Ratio -31.66
Price-to-Sales 826.51
Price-to-Book 15.16
PEG Ratio 1.78
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 83.75
Resistance 3 (R3) 83.43 81.79 83.09
Resistance 2 (R2) 81.79 80.78 81.95 82.87
Resistance 1 (R1) 80.79 80.16 81.29 81.11 82.65
Pivot Point 79.15 79.15 79.40 79.31 79.15
Support 1 (S1) 78.15 78.14 78.65 78.47 76.93
Support 2 (S2) 76.51 77.52 76.67 76.71
Support 3 (S3) 75.51 76.51 76.49
Support 4 (S4) 75.83